news
HPLC market to grow by $1.26bn in five years
Increasing uses of high-performance liquid chromatography (HPLC) and rising healthcare investment driving market growth, finds report.
List view / Grid view
Waters
video
Video: Introducing the new SYNAPT XS High Resolution Mass Spectrometer
Introduced at ASMS 2019, the new SYNAPT XS provides ultimate flexibility offering greater freedom of analytical choice to support scientific creativity and technical success for any application.
article
Biopharma Processing & Development In-Depth Focus 2019
Today’s biopharmaceutical developers need accurate and precise information at all stages of research and development in order to bring safe and effective therapies to patients. This in-depth focus features novel perspectives from industry experts that serve to illustrate which technologies and systems are benefitting this cause.
news
Waters Corporation to invest $215 million in precision chemistry manufacturing in Massachusetts
New state-of-the-art facility will support continued growth and innovation...
news
Waters technologies for food safety, food authenticity and biomedical research at ASMS 2018
Creating access to the power and potential of mass spectrometry for more laboratories...
news
Waters new ACQUITY UPLC PLUS Series sets new performance benchmarks
Next-Generation UPLC Platform designed to keep pace with evolving laboratory requirements for chromatographic performance...
news
Waters New ACQUITY Arc Bio System brings advanced method transfer capabilities to routine bioseparations
Waters Corporation (NYSE:WAT) today introduced the Waters® ACQUITY™ Arc™ Bio System, a versatile, iron-free, bio-inert, quaternary liquid chromatograph specifically engineered to enable the efficient transfer and improvement of bioseparation analytical methods regardless of the LC platform on which the original method was developed...
news
Waters BioResolve RP mAb Polyphenyl Columns, setting a new standard for reversed-phase separations of Monoclonal Antibodies and Antibody Drug Conjugates
Waters Corporation (NYSE:WAT) today introduced BioResolve™ RP mAb Polyphenyl 450 angstrom 2.7 micron solid core Columns intended for the reversed-phase analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) using LC-UV and LC-MS...
article
Application Notes & Whitepapers 2017
This supplement contains a collection of application notes and whitepapers from some of the leading suppliers to the pharmaceutical industry...
whitepaper
Whitepaper: Dwell Volume and Extra-Column Volume: What are they and how do they impact method transfer
Method transfer or method scaling across different instrument platforms can be affected by both dwell volume and extra-column dispersion...
content_hub
Waters Corporation
7 December 2017 | By
Waters is an Analytical Laboratory instrument and software company which markets to the laboratory-dependent organisation in these market areas: liquid chromatography, mass spectrometry, supercritical fluid chromatography, laboratory informatics, rheometry and microcalorimetry. Since 1958, Waters Corporation has been in the business of making innovative analytical instruments that assist scientists in reaching…
product
Acquity UPC2® System
Dr. Isabelle Francois discusses the advantages of the ACQUITY UPC2 System and its ability to create selective separations of structurally similar chiral and achiral compounds.
product
CORTECS® COLUMNS
Jonathan Turner introduces the CORTECS T3 Column, ideally suited for separating polar and nonpolar compounds in reversed phase chromatography.
product
Waters ACQUITY QDa Mass Detector
Dr. Paula Hong discusses flexibility, sensitivity, and ease of use with the ACQUITY QDa Mass Detector.
product
ACQUITY Arc System for HPLC and UHPLC
Dr. Paula Hong demonstrates the flexibility of the ACQUITY Arc System by switching between HPLC and UHPLC separations.
